COMP: An endogenous thrombin inhibitor
Open access via publisher
MetadataShow full item record
In this issue of Blood, Liang and colleagues<sup>1</sup> demonstrate that cartilage oligomeric matrix protein (COMP) acts as a major endogenous plasma- and platelet-derived inhibitor of thrombin activity in vitro and in vivo.
Metharom, P. and Berndt, M. 2015. COMP: An endogenous thrombin inhibitor. Blood. 126 (7): pp. 831-832.
Faculty of Health Sciences